Carbamazepine vs Phenytoin
- 1 January 1979
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 36 (1), 22-24
- https://doi.org/10.1001/archneur.1979.00500370052010
Abstract
• The antiepileptic effects of carbamazepine and phenytoin were compared in a double-blind crossover trial studying patients with primary and secondary generalized seizures and partial seizures with motor symptoms. Each treatment period lasted ten weeks. The patients were seen every two weeks, and doses were adjusted according to plasma levels. It was attempted to keep levels in the optimal plasma range, ie, 10 to 20 and 4 to 10 mg/liter for phenytoin and carbamazepine, respectively. Twenty-three patients entered and 19 completed the study. No statistically significant differences were found between carbamazepine and phenytoin with regard to seizure control and acute side effects.This publication has 9 references indexed in Scilit:
- Carbamazepine—A double‐blind comparison with phenytoinNeurology, 1977
- Clinical Pharmacokinetics of AnticonvulsantsClinical Pharmacokinetics, 1976
- PLASMA LEVEL AND EFFECT OF CARBAMAZEPINE IN GRAND MAL AND PSYCHOMOTOR EPILEPSYActa Neurologica Scandinavica, 1975
- The Effects of Carbamazepine on Patients with Psychomotor Epilepsy: Results of a Double‐Blind StudyEpilepsia, 1974
- Carbamazepine as an anticonvulsantNeurology, 1974
- The Treatment of Epileptic Children with Carbamazepine Follow‐up Studies of Clinical Course and EEG*Epilepsia, 1972
- Rapid determination of diphenylhydantoin in blood plasma by gas-liquid chromatographyAnalytical Chemistry, 1970
- The Two-Period Change-Over Design and Its Use in Clinical TrialsBiometrics, 1965